If you have been reading about Stenabolic and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-22. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
The UK provides the Operational Ration Pack, General Purpose. Packed inside a small cardboard box, each ration has enough retort-pouched and canned foods to feed one soldier for 24 hours. Seven menus (plus vegetarian and religious variants) provide two precooked meals (Breakfast and Main Meal) plus a midday snack. Example (Menu A) Breakfast: Hamburger and beans, Instant Porridge. All ration packs also contain Oatmeal Block, Fruit Biscuits, Biscuits Brown (a more compact alternative to bread), a sachet of instant soup and jam or yeast extract (a Marmite like spread) for a lunchtime snack, and chocolate (in the form of a specially made Yorkie bar which is flatter than civilian bars, or, more recently, a simple unbranded bar of milk chocolate), though this has been phased out with the introduction of the more recent multi-climate ration packs, and boiled sweets (hard candy) for snacking whilst on patrol, or in free time. Main Meal: Instant soup, Chicken with Mushroom and Pasta, Treacle Pudding. Each pack also contains instant coffee, tea bags, creamer, sugar, hot cocoa mix, beef/vegetable stock powder, lemon/orange powder or Lucozade electrolyte powder, matches, packet of tissues, chewing-gum, a small bottle of Tabasco sauce, and water purifying tablets. They sometimes also contain chicken and herb pâté. Also available are Kosher/Halal, Vegetarian, and Hindu/Sikh specific menus. Regardless of their contents, these ration packs are referred to as Rat-Packs or Compo (short for Composite Rations) by the soldiers who eat them.
Diatomite forms by the accumulation of the amorphous silica (opal, SiO2·nH2O) remains of dead diatoms (microscopic single-celled algae) in lake sediment or marine sediments. The fossil remains consist of a pair of symmetrical shells or frustules. Marine diatomites are found in association with a wide variety of other rock types but lacustrine diatomites are almost always associated with volcanic rock. Diatomaceous chert consists of diatomite that has been cemented with silica. Diatoms are able to extract silica from water that is less than 1% saturated in amorphous silica (saturation index (SI): -2). Their frustules remain undissolved because they are surrounded by an organic matrix. Clay minerals may also precipitate on the frustules and protect them from dissolution in sea water. When the diatom dies, the frustule is stripped of its organic layer and exposed to sea water. As a result, only 1% to 10% of frustules survive long enough to be buried under sediments and some of this is dissolved within the sediments. Only an estimated 0.05% to 0.15% of the original amount of silica produced by diatoms is preserved in the sedimentary record.
The female is gravid for 50 to 59 days. The king cobra is the only snake that builds a nest using dry leaf litter, starting from late March to late May. Most nests are located at the base of trees, are up to 55 cm (22 in) high in the centre and 140 cm (55 in) wide at the base. They consist of several layers and have mostly one chamber, into which the female lays eggs. Clutch size ranges from 7 to 43 eggs, with 6 to 38 eggs hatching after incubation periods of 66 to 105 days. Temperature inside nests is not steady but varies depending on elevation from 13.5 to 37.4 °C (56.3 to 99.3 °F). Females stay by their nests between two and 77 days. Hatchlings are between 37.5 and 58.5 cm (14.8 and 23.0 in) long and weigh 9 to 38 g (0.32 to 1.34 oz). The king cobra was shown to be capable of facultative parthenogenesis. The parthenogenetic mechanism appears to be a variation of meiosis referred to as terminal fusion automixis in which there is fusion of the meiotic products formed at the anaphase II stage of meiosis. The venom of hatchlings is as potent as that of the adults. They may be brightly marked, but these colours often fade as they mature. They are alert and nervous, being highly aggressive if disturbed. The average lifespan of a wild king cobra is about 20 years.
Spelt (Triticum spelta), also known as dinkel wheat, is a species of wheat. It is a relict crop, eaten in Central Europe and northern Spain. It is high in protein. In Australia it is marketed as a health food. Spelt was cultivated from the Neolithic period onward. It was a staple food in parts of Europe from the Bronze Age to the Middle Ages. It is used in baking, and is made into bread, pasta, and beer. It is sometimes considered a subspecies of the closely related common wheat (T. aestivum), with the botanical name Triticum aestivum subsp. spelta. It is a hexaploid, most likely a hybrid of wheat and emmer.
Sources: en.wikipedia.org
Although protests against Bukele occurred in 2020 during the COVID-19 pandemic and in 2023 about his re-election campaign and gang crackdown, he has retained high job-approval ratings throughout his presidency. Bukele's approval rating has never gone below 75 percent, and has averaged in the 90s. He is one of the most popular presidents in Salvadoran history, and the Los Angeles Times' Kate Linthicum called him "one of the most popular leaders in the world". The United States Institute of Peace's Mary Speck referred to Bukele as "Latin America's — and possibly the world's — most popular leader". Risa Grais-Targow, a director at the Eurasia Group, described Bukele's approval rating as "sky-high" and "really unprecedented". In addition to Bukele's domestic popularity, he is also very popular among Salvadorans living in the United States and throughout Latin America. Some Latin American state leaders and other politicians have sought to emulate his government policies. In some countries, such as Colombia and Ecuador, opinion polls found Bukele more popular with their residents than domestic politicians. Steven Levitsky, a political scientist and the director of Harvard University's Latin American studies center, wrote that "everybody wants to be a Bukele" and compared his popularity across Latin America to that of former Venezuelan president Hugo Chávez. Some political analysts consider Bukele's popularity a cult of personality.
=== Half-Life: Hostile Takeover === On November 23, 1999, GameSpot reported that 2015 was developing a Half-Life expansion pack to follow Half-Life: Opposing Force. On March 18, 2000, the Adrenaline Vault reported that the expansion was named Half-Life: Hostile Takeover and that it had appeared on retail product lists with a release date of late August. On August 7, the Adrenaline Vault reported that Sierra, the publisher of Half-Life, had informed them that Hostile Takeover had been canceled. The stock keeping unit for Hostile Takeover was repurposed by online retailers for Half-Life: Counter-Strike. On June 21, 2001, Valve filed a video game trademark for "Hostile Takeover". After several extensions, the trademark expired on October 3, 2004.
The concentration of hormones required for plant responses are very low (10−6 to 10−5 mol/L). Because of these low concentrations, it has been very difficult to study plant hormones, and only since the late 1970s have scientists been able to start piecing together their effects and relationships to plant physiology. Much of the early work on plant hormones involved studying plants that were genetically deficient in one or involved the use of tissue-cultured plants grown in vitro that were subjected to differing ratios of hormones, and the resultant growth compared. The earliest scientific observation and study dates to the 1880s; the determination and observation of plant hormones and their identification was spread out over the next 70 years. Synergism in plant hormones refers to the how of two or more hormones result in an effect that is more than the individual effects. For example, auxins and cytokinins often act in cooperation during cellular division and differentiation. Both hormones are key to cell cycle regulation, but when they come together, their synergistic interactions can enhance cell proliferation and organogenesis more effectively than either could in isolation.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.